ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders.

[1]  Jinpeng Liu,et al.  ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer , 2023, Cancers.

[2]  Justin R. Smith,et al.  Intercellular Adhesion Molecule 1: More than a Leukocyte Adhesion Molecule , 2023, Biology.

[3]  Weifeng Tang,et al.  Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications , 2022, Frontiers in Oncology.

[4]  Tianzhou Liu,et al.  Functional and clinical characteristics of focal adhesion kinases in cancer progression , 2022, Frontiers in Cell and Developmental Biology.

[5]  Yuan Zhang,et al.  Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19 , 2022, International journal of biological sciences.

[6]  Y. Liu,et al.  Serum VCAM‐1 and ICAM‐1 measurement assists for MACE risk estimation in ST‐segment elevation myocardial infarction patients , 2022, Journal of clinical laboratory analysis.

[7]  Yang Zhao,et al.  A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis , 2022, Frontiers in Oncology.

[8]  D. Okuzaki,et al.  Resistin Associated With Cytokines and Endothelial Cell Adhesion Molecules Is Related to Worse Outcome in COVID-19 , 2022, Frontiers in Immunology.

[9]  E. Walters,et al.  Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases , 2022, Inflammopharmacology.

[10]  J. Knight,et al.  Endothelial Cell–Activating Antibodies in COVID‐19 , 2022, Arthritis & rheumatology.

[11]  Jihong Han,et al.  Combination of Colchicine and Ticagrelor Inhibits Carrageenan-Induced Thrombi in Mice , 2022, Oxidative medicine and cellular longevity.

[12]  I. Ismawati,et al.  Effect of Proteasome Inhibitor on Vascular Cell Adhesion Molecule-1 (VCAM-1) and Intercellular Adhesion Molecule-1 (ICAM-1) Expressions in Rat Model of Atherosclerosis. , 2022, Reports of biochemistry & molecular biology.

[13]  S. Bhatia,et al.  CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target , 2021, Science of The Total Environment.

[14]  V. Dwivedi,et al.  Gene regulation of Intracellular adhesion Molecule-1 (ICAM-1): A molecule with multiple functions. , 2021, Immunology letters.

[15]  S. Kohlhoff,et al.  Intracellular Adhesion Molecule-1 (ICAM-1) Levels in Convalescent COVID-19 Serum: A Case Report. , 2021, Annals of clinical and laboratory science.

[16]  Xiaomin Wang,et al.  Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer , 2021, Aging.

[17]  M. Aslan,et al.  Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells , 2021, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  Yang Shen,et al.  ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer , 2021, Nature Communications.

[19]  W. Yeh,et al.  Regulatory effects of IL-1β in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1. , 2021, European journal of pharmacology.

[20]  Fernanda Sanhueza-Olivares,et al.  VCAM-1 as a predictor biomarker in cardiovascular disease. , 2021, Biochimica et biophysica acta. Molecular basis of disease.

[21]  Arvind Singh Tomar,et al.  Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis , 2021, JHEP Reports.

[22]  T. Welte,et al.  Between inflammation and thrombosis: endothelial cells in COVID-19 , 2021, European Respiratory Journal.

[23]  D. Yap,et al.  Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis , 2021, Lupus.

[24]  P. Krishan,et al.  Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study , 2021, International Journal of Angiology.

[25]  K. Domschke,et al.  Upregulation of sICAM-1 and sVCAM-1 Levels in the Cerebrospinal Fluid of Patients with Schizophrenia Spectrum Disorders , 2020, Diagnostics.

[26]  G. Duan,et al.  Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches , 2020, Signal Transduction and Targeted Therapy.

[27]  S. Carlier,et al.  VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques , 2020, Biology.

[28]  R. Ferrari,et al.  Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients , 2020, Critical Care.

[29]  Lei Zhang,et al.  ICAM-1 deletion delays the repair process in aging diabetic mice. , 2020, Metabolism: clinical and experimental.

[30]  Weiliang Tang,et al.  Resveratrol prevents TNF-α-induced VCAM-1 and ICAM-1 upregulation in endothelial progenitor cells via reduction of NF-κB activation , 2020, The Journal of international medical research.

[31]  S. Nagashima,et al.  Endothelial Dysfunction and Thrombosis in Patients With COVID-19—Brief Report , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[32]  A. Hamdan,et al.  Trihoney Suppresses Soluble Adhesion Molecules (ICAM-1 and VCAM-1 in Hypercholesterolemic Atherosclerotic Rabbits: A Comparative Study with Atorvastatin , 2020, Sains Malaysiana.

[33]  L. Zou,et al.  Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients , 2020, The Journal of infectious diseases.

[34]  L. Frich,et al.  Acute Neurofilament Light Chain Plasma Levels Correlate With Stroke Severity and Clinical Outcome in Ischemic Stroke Patients , 2020, Frontiers in Neurology.

[35]  U. Müller-Ladner,et al.  Adipokines and Inflammation Alter the Interaction Between Rheumatoid Arthritis Synovial Fibroblasts and Endothelial Cells , 2020, Frontiers in Immunology.

[36]  R. Sumagin,et al.  ICAM‐1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis , 2020, Journal of leukocyte biology.

[37]  A. V. D. Stolpe,et al.  Intercellular adhesion molecule-1 , 2020, Journal of Molecular Medicine.

[38]  N. Müller.  The Role of Intercellular Adhesion Molecule-1 in the Pathogenesis of Psychiatric Disorders , 2019, Front. Pharmacol..

[39]  G. Meneses,et al.  Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure , 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[40]  M. Jeong,et al.  Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice , 2019, Clinical Hypertension.

[41]  Liling Tang,et al.  The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review , 2019, Journal of Experimental & Clinical Cancer Research.

[42]  S. Fagerholm,et al.  Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment , 2019, Front. Immunol..

[43]  Ping Liu,et al.  Kaempferol inhibits multiple pathways involved in the secretion of inflammatory mediators from LPS‑induced rat intestinal microvascular endothelial cells. , 2018, Molecular medicine reports.

[44]  D. Jeste,et al.  Abnormal levels of vascular endothelial biomarkers in schizophrenia , 2018, European Archives of Psychiatry and Clinical Neuroscience.

[45]  M. Lačković,et al.  sVCAM-1, sICAM-1, TNF-α and IL-6 levels in bipolar disorder type I: Acute, longitudinal and therapeutic implications , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[46]  Yang Shen,et al.  Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models. , 2018, Cancer discovery.

[47]  B. Giusti,et al.  Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke , 2018, European stroke journal.

[48]  A. Ortiz,et al.  Inflammation in Diabetic Kidney Disease , 2018, Nephron.

[49]  I. Melero,et al.  ICAM-1-LFA-1 Dependent CD8+ T-Lymphocyte Aggregation in Tumor Tissue Prevents Recirculation to Draining Lymph Nodes , 2018, Front. Immunol..

[50]  W. Reinisch,et al.  Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1. , 2018, Journal of Crohn's & colitis.

[51]  P. Colarusso,et al.  Inhibiting focal adhesion kinase (FAK) blocks IL‐4 induced VCAM‐1 expression and eosinophil recruitment in vitro and in vivo , 2018, Journal of leukocyte biology.

[52]  M. R. Kim,et al.  Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer , 2018, International journal of molecular sciences.

[53]  J. Huot,et al.  Endothelial microRNAs regulating the NF‐κB pathway and cell adhesion molecules during inflammation , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  M. Maes,et al.  Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels , 2018, Lupus.

[55]  R. Cano,et al.  New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases , 2018, Front. Immunol..

[56]  B. Arteta,et al.  Role of liver ICAM-1 in metastasis. , 2017, Oncology letters.

[57]  M. Mayr,et al.  Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation , 2017, JAMA cardiology.

[58]  M. Wiciński,et al.  Evaluation of VCAM-1 and ICAM-1 concentration and values of global tests concerning the coagulation system of patients suffering from subarachnoid haemorrage. , 2016, Annals of agricultural and environmental medicine : AAEM.

[59]  M. Lačković,et al.  Role of sICAM-1 and sVCAM-1 as biomarkers in early and late stages of schizophrenia. , 2016, Journal of psychiatric research.

[60]  D. Ramji,et al.  Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets , 2015, Cytokine & growth factor reviews.

[61]  Yanjie Ding,et al.  Role and mechanism of vascular cell adhesion molecule-1 in the development of rheumatoid arthritis. , 2015, Experimental and therapeutic medicine.

[62]  J. Jung,et al.  Interaction of tetraspan(in) TM4SF5 with CD44 promotes self‐renewal and circulating capacities of hepatocarcinoma cells , 2015, Hepatology.

[63]  Parth Malik,et al.  Intercellular adhesion molecule‐1 as a drug target in asthma and rhinitis , 2014, Respirology.

[64]  B. Leonard.  Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65]  S. Johnston,et al.  An Anti-Human ICAM-1 Antibody Inhibits Rhinovirus-Induced Exacerbations of Lung Inflammation , 2013, PLoS pathogens.

[66]  L. Vanhamme,et al.  Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies , 2013, Mediators of inflammation.

[67]  A. Reiner,et al.  Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the Coronary Artery Risk Development in Young Adults Study. , 2012, Clinical chemistry.

[68]  H. Abdala-Valencia,et al.  Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. , 2011, Antioxidants & redox signaling.

[69]  V. Demarin,et al.  Role of cell adhesion molecules in acute ischemic stroke , 2011, Annals of Saudi medicine.

[70]  C. Lawson,et al.  ICAM-1 signaling in endothelial cells , 2009, Pharmacological reports : PR.

[71]  A. Postadzhiyan,et al.  Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. , 2008, Clinical biochemistry.

[72]  P. Oschmann,et al.  Time course of VCAM‐1 and ICAM‐1 in CSF in patients with basal ganglia haemorrhage , 2007, Acta neurologica Scandinavica.

[73]  T. Vlaykova,et al.  Adhesion molecules in chronic ulcerative colitis , 2007, International Journal of Colorectal Disease.

[74]  H. Lowe,et al.  ICAM-1 in acute myocardial infarction: a potential therapeutic target. , 2007, Current molecular medicine.

[75]  M. Kudo,et al.  Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. , 2006, Hepato-gastroenterology.

[76]  A. Erbay,et al.  Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. , 2006, International journal of cardiology.

[77]  Y. Kurozawa,et al.  Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer. , 2005, European journal of cancer.

[78]  A. Evans,et al.  Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. , 2003, Atherosclerosis.

[79]  C. Macías,et al.  [Endothelial adhesion molecules ICAM-1, VCAM-1 and E-selectin in patients with acute coronary syndrome]. , 2003, Revista espanola de cardiologia.

[80]  C. Malone,et al.  Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. , 2002, European journal of cancer.

[81]  P. Klimiuk,et al.  Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis , 2002, Annals of the rheumatic diseases.

[82]  I. Campbell,et al.  Vascular cell adhesion molecule‐1 (VCAM‐1) blockade in collagen‐induced arthritis reduces joint involvement and alters B cell trafficking , 2002, Clinical and experimental immunology.

[83]  T. Hanafusa,et al.  Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. , 2001, American journal of hypertension.

[84]  L. Truong,et al.  Expression of Adhesion Molecules in Kidney with Experimental Chronic Obstructive Uropathy: The Pathogenic Role of ICAM-1 and VCAM-1 , 2000, Nephron.

[85]  F. Yamasawa,et al.  Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[86]  M. Sans,et al.  VCAM-1, but Not ICAM-1 or MAdCAM-1, Immunoblockade Ameliorates DSS-Induced Colitis in Mice , 2000, Laboratory Investigation.

[87]  M. Sans,et al.  VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. , 1999, Gastroenterology.

[88]  Paul Wordsworth,et al.  A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. , 1997, British journal of rheumatology.

[89]  C. Janson,et al.  Increased adhesion to vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 of eosinophils from patients with asthma. , 1995, The Journal of allergy and clinical immunology.

[90]  N. Sarrafzadegan,et al.  Effect of Endothelial Adhesion Molecules on Atrial Fibrillation: A Systematic Review and Meta-analysis. , 2022, Heart international.

[91]  M. Lačković,et al.  Predictive value of sICAM-1 and sVCAM-1 as biomarkers of affective temperaments in healthy young adults. , 2017, Journal of affective disorders.

[92]  L. Adel,et al.  Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease. , 2011, The Egyptian journal of immunology.

[93]  M. Szczepańska,et al.  Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure , 2004, Pediatric Nephrology.